Global Gene Therapy Market Research Report 2026

Global Gene Therapy Market Research Report 2026

Pages: 210

Format: PDF

Date: 01-2026

Global Gene Therapy Market Report

Market Overview

Gene therapy involves the modification, replacement, or regulation of defective genes to treat or prevent diseases. It is applied through ex vivo (outside the body, then reintroduced) or in vivo (direct delivery into the patient) approaches. The technology is increasingly used in oncology, rare genetic disorders, cardiovascular diseases, and infectious diseases.

The global market is expected to grow significantly, driven by advances in vector technology, rising prevalence of genetic disorders, increasing investments in R&D, and regulatory approvals of novel therapies.

Key Market Players

Beyond the listed companies, several additional players contribute significantly to the global gene therapy market:

  • Sangamo Therapeutics (U.S.)
  • Spark Therapeutics (U.S.)
  • Dimension Therapeutics (U.S.)
  • Avalanche Biotechnologies (U.S.)
  • Celladon Corporation (U.S.)
  • Vical Incorporated (U.S.)
  • Advantagene Inc. (U.S.)
  • Bluebird Bio (U.S.)
  • Novartis AG (Switzerland) – CAR-T and gene therapy portfolio.
  • Gilead Sciences/Kite Pharma (U.S.) – oncology-focused gene therapies.
  • Pfizer Inc. (U.S.) – expanding pipeline in rare diseases.
  • Roche/Genentech (Switzerland/U.S.) – oncology and ophthalmology gene therapies.
  • UniQure N.V. (Netherlands) – pioneering AAV-based therapies.
  • REGENXBIO Inc. (U.S.) – AAV vector technology.
  • Orchard Therapeutics (U.K.) – rare disease therapies.
  • Editas Medicine (U.S.) – CRISPR-based gene editing.
  • CRISPR Therapeutics (Switzerland) – gene editing for blood disorders.
  • Intellia Therapeutics (U.S.) – in vivo CRISPR therapies.
  • Beam Therapeutics (U.S.) – base editing technologies.

Segments Analysis

By Product Type

  • Ex vivo Gene Therapy – cells modified outside the body and reintroduced.
  • In vivo Gene Therapy – direct delivery of genetic material into the patient.

By Application

  • Cancer Diseases – CAR-T therapies, tumor suppressor gene delivery.
  • Monogenic Diseases – hemophilia, muscular dystrophy, cystic fibrosis.
  • Infectious Diseases – HIV, hepatitis, emerging viral infections.
  • Cardiovascular Diseases – ischemic heart disease, heart failure.
  • Others – ophthalmology, neurology, metabolic disorders.

Regional Analysis – Highlights

  • North America: Largest market; strong presence of biotech firms, advanced healthcare infrastructure, and FDA approvals.
  • Europe: Germany, U.K., and France lead; EMA supports rare disease therapies.
  • Asia-Pacific: China and Japan expanding R&D; India and South Korea emerging with clinical trials.
  • Latin America: Brazil and Argentina show growing adoption in oncology and rare disease treatments.
  • Middle East & Africa: Early-stage adoption; demand linked to healthcare modernization and rare disease initiatives.

Porter’s Five Forces

  1. Threat of New Entrants – Moderate (high R&D costs and regulatory hurdles, but growing biotech startups).
  2. Bargaining Power of Suppliers – Moderate (specialized vectors and raw materials impact costs).
  3. Bargaining Power of Buyers – High (patients, hospitals, and insurers demand affordability and efficacy).
  4. Threat of Substitutes – Moderate (cell therapies, RNA-based therapies, traditional pharmaceuticals).
  5. Industry Rivalry – High (intense competition among biotech firms and pharmaceutical giants).

SWOT Analysis

Strengths

  • Potential for curative treatments.
  • Strong pipeline of therapies across multiple indications.
  • Increasing regulatory approvals.

Weaknesses

  • High treatment costs limit accessibility.
  • Complex manufacturing and logistics.
  • Long regulatory timelines.

Opportunities

  • Expansion into rare and orphan diseases.
  • Growth in CRISPR and next-gen editing technologies.
  • Rising investments in Asia-Pacific biotech hubs.

Threats

  • Ethical and safety concerns.
  • Competition from alternative therapies.
  • Reimbursement challenges in developing markets.

Trend Analysis

  • Rise of CRISPR and base editing technologies.
  • Expansion of CAR-T and immuno-oncology applications.
  • Growth in rare disease approvals and orphan drug incentives.
  • Integration of AI in gene therapy R&D.
  • Increasing partnerships between biotech startups and pharma giants.

Drivers & Challenges

Drivers

  • Rising prevalence of genetic and rare diseases.
  • Increasing regulatory approvals of novel therapies.
  • Expanding investments in biotech R&D.
  • Growing demand for personalized medicine.

Challenges

  • High treatment costs and reimbursement barriers.
  • Manufacturing complexity and scalability issues.
  • Ethical concerns over genetic modification.
  • Regulatory hurdles across different regions.

Value Chain Analysis

  1. Raw Materials – viral vectors, plasmids, CRISPR components.
  2. Production Technologies – ex vivo modification, in vivo delivery, vector engineering.
  3. Manufacturing & Processing – GMP facilities for gene therapy production.
  4. Distribution Channels – hospitals, specialty clinics, direct partnerships with healthcare providers.
  5. End-Use Industries – oncology, rare diseases, cardiovascular, infectious diseases.

Quick Recommendations for Stakeholders

  • Manufacturers: Invest in scalable vector production and next-gen editing technologies.
  • Investors: Focus on rare disease therapies and CRISPR-based startups.
  • Governments & Regulators: Strengthen frameworks for approvals and reimbursement.
  • Healthcare Providers: Expand infrastructure for advanced therapies.
  • R&D Teams: Innovate delivery systems for in vivo therapies.
  • Supply Chain Managers: Secure reliable sources of vectors and raw materials.

 

Table of Contents

Global Gene Therapy
1 Gene Therapy Market Overview
    1.1 Product Overview and Scope of Gene Therapy
    1.2 Classification of Gene Therapy by Product Category
        1.2.1 Global Gene Therapy Market Size (Sales) Comparison by Type
        1.2.2 Global Gene Therapy Market Size (Sales) Market Share by Type (Product Category) in
        1.2.3 Ex vivo
        1.2.4 In vivo
    1.3 Global Gene Therapy Market by Application/End Users
        1.3.1 Global Gene Therapy Sales (Volume) and Market Share Comparison by Application
        1.3.1 Cancer Diseases
        1.3.2 Monogenic Diseases
        1.3.3 Infectious Diseases
        1.3.4 Cardiovascular Diseases
        1.3.5 Others
    1.4 Global Gene Therapy Market by Region
        1.4.1 Global Gene Therapy Market Size (Value) Comparison by Region
        1.4.2 United States Gene Therapy Status and Prospect
        1.4.3 Europe Gene Therapy Status and Prospect
        1.4.4 China Gene Therapy Status and Prospect
        1.4.5 Japan Gene Therapy Status and Prospect
        1.4.6 Southeast Asia Gene Therapy Status and Prospect
        1.4.7 India Gene Therapy Status and Prospect
    1.5 Global Market Size (Value and Volume) of Gene Therapy
        1.5.1 Global Gene Therapy Sales and Growth Rate
        1.5.2 Global Gene Therapy Revenue and Growth Rate

2 Global Gene Therapy Competition by Players/Suppliers, Type and Application
     2.1 Global Gene Therapy Market Competition by Players/Suppliers
        2.1.1 Global Gene Therapy Sales and Market Share of Key Players/Suppliers
        2.1.2 Global Gene Therapy Revenue and Share by Players/Suppliers
    2.2 Global Gene Therapy (Volume and Value) by Type
        2.2.1 Global Gene Therapy Sales and Market Share by Type
        2.2.2 Global Gene Therapy Revenue and Market Share by Type
    2.3 Global Gene Therapy (Volume and Value) by Region
        2.3.1 Global Gene Therapy Sales and Market Share by Region
        2.3.2 Global Gene Therapy Revenue and Market Share by Region
    2.4 Global Gene Therapy (Volume) by Application

3 United States Gene Therapy (Volume, Value and Sales Price)
    3.1 United States Gene Therapy Sales and Value
        3.1.1 United States Gene Therapy Sales and Growth Rate
        3.1.2 United States Gene Therapy Revenue and Growth Rate
        3.1.3 United States Gene Therapy Sales Price Trend
    3.2 United States Gene Therapy Sales Volume and Market Share by Players
    3.3 United States Gene Therapy Sales Volume and Market Share by Type
    3.4 United States Gene Therapy Sales Volume and Market Share by Application

4 Europe Gene Therapy (Volume, Value and Sales Price)
    4.1 Europe Gene Therapy Sales and Value
        4.1.1 Europe Gene Therapy Sales and Growth Rate
        4.1.2 Europe Gene Therapy Revenue and Growth Rate
        4.1.3 Europe Gene Therapy Sales Price Trend
    4.2 Europe Gene Therapy Sales Volume and Market Share by Players
    4.3 Europe Gene Therapy Sales Volume and Market Share by Type
    4.4 Europe Gene Therapy Sales Volume and Market Share by Application

5 China Gene Therapy (Volume, Value and Sales Price)
    5.1 China Gene Therapy Sales and Value
        5.1.1 China Gene Therapy Sales and Growth Rate
        5.1.2 China Gene Therapy Revenue and Growth Rate
        5.1.3 China Gene Therapy Sales Price Trend
    5.2 China Gene Therapy Sales Volume and Market Share by Players
    5.3 China Gene Therapy Sales Volume and Market Share by Type
    5.4 China Gene Therapy Sales Volume and Market Share by Application

6 Japan Gene Therapy (Volume, Value and Sales Price)
    6.1 Japan Gene Therapy Sales and Value
        6.1.1 Japan Gene Therapy Sales and Growth Rate
        6.1.2 Japan Gene Therapy Revenue and Growth Rate
        6.1.3 Japan Gene Therapy Sales Price Trend
    6.2 Japan Gene Therapy Sales Volume and Market Share by Players
    6.3 Japan Gene Therapy Sales Volume and Market Share by Type
    6.4 Japan Gene Therapy Sales Volume and Market Share by Application

7 Southeast Asia Gene Therapy (Volume, Value and Sales Price)
    7.1 Southeast Asia Gene Therapy Sales and Value
        7.1.1 Southeast Asia Gene Therapy Sales and Growth Rate
        7.1.2 Southeast Asia Gene Therapy Revenue and Growth Rate
        7.1.3 Southeast Asia Gene Therapy Sales Price Trend
    7.2 Southeast Asia Gene Therapy Sales Volume and Market Share by Players
    7.3 Southeast Asia Gene Therapy Sales Volume and Market Share by Type
    7.4 Southeast Asia Gene Therapy Sales Volume and Market Share by Application

8 India Gene Therapy (Volume, Value and Sales Price)
    8.1 India Gene Therapy Sales and Value
        8.1.1 India Gene Therapy Sales and Growth Rate
        8.1.2 India Gene Therapy Revenue and Growth Rate
        8.1.3 India Gene Therapy Sales Price Trend
    8.2 India Gene Therapy Sales Volume and Market Share by Players
    8.3 India Gene Therapy Sales Volume and Market Share by Type
    8.4 India Gene Therapy Sales Volume and Market Share by Application

9 Global Gene Therapy Players/Suppliers Profiles and Sales Data
    9.1 Sangamo
        9.1.1 Company Basic Information, Manufacturing Base and Competitors
        9.1.2 Gene Therapy Product Category, Application and Specification
            9.1.2.1 Product A
            9.1.2.2 Product B
        9.1.3 Sangamo Gene Therapy Sales, Revenue, Price and Gross Margin
        9.1.4 Main Business/Business Overview
    9.2 Spark Therapeutics
        9.2.1 Company Basic Information, Manufacturing Base and Competitors
        9.2.2 Gene Therapy Product Category, Application and Specification
            9.2.2.1 Product A
            9.2.2.2 Product B
        9.2.3 Spark Therapeutics Gene Therapy Sales, Revenue, Price and Gross Margin
        9.2.4 Main Business/Business Overview
    9.3 Dimension Therapeutics
        9.3.1 Company Basic Information, Manufacturing Base and Competitors
        9.3.2 Gene Therapy Product Category, Application and Specification
            9.3.2.1 Product A
            9.3.2.2 Product B
        9.3.3 Dimension Therapeutics Gene Therapy Sales, Revenue, Price and Gross Margin
        9.3.4 Main Business/Business Overview
    9.4 Avalanche Bio
        9.4.1 Company Basic Information, Manufacturing Base and Competitors
        9.4.2 Gene Therapy Product Category, Application and Specification
            9.4.2.1 Product A
            9.4.2.2 Product B
        9.4.3 Avalanche Bio Gene Therapy Sales, Revenue, Price and Gross Margin
        9.4.4 Main Business/Business Overview
    9.5 Celladon
        9.5.1 Company Basic Information, Manufacturing Base and Competitors
        9.5.2 Gene Therapy Product Category, Application and Specification
            9.5.2.1 Product A
            9.5.2.2 Product B
        9.5.3 Celladon Gene Therapy Sales, Revenue, Price and Gross Margin
        9.5.4 Main Business/Business Overview
    9.6 Vical
        9.6.1 Company Basic Information, Manufacturing Base and Competitors
        9.6.2 Gene Therapy Product Category, Application and Specification
            9.6.2.1 Product A
            9.6.2.2 Product B
        9.6.3 Vical Gene Therapy Sales, Revenue, Price and Gross Margin
        9.6.4 Main Business/Business Overview
    9.7 Advantagene
        9.7.1 Company Basic Information, Manufacturing Base and Competitors
        9.7.2 Gene Therapy Product Category, Application and Specification
            9.7.2.1 Product A
            9.7.2.2 Product B
        9.7.3 Advantagene Gene Therapy Sales, Revenue, Price and Gross Margin
        9.7.4 Main Business/Business Overview
    ...

10 Gene Therapy Maufacturing Cost Analysis
    10.1 Gene Therapy Key Raw Materials Analysis
        10.1.1 Key Raw Materials
        10.1.2 Price Trend of Key Raw Materials
        10.1.3 Key Suppliers of Raw Materials
        10.1.4 Market Concentration Rate of Raw Materials
    10.2 Proportion of Manufacturing Cost Structure
        10.2.1 Raw Materials
        10.2.2 Labor Cost
        10.2.3 Manufacturing Process Analysis of Gene Therapy
    10.3 Manufacturing Process Analysis of Gene Therapy

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
    11.1 Gene Therapy Industrial Chain Analysis
    11.2 Upstream Raw Materials Sourcing
    11.3 Raw Materials Sources of Gene Therapy Major Manufacturers in
    11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
    12.1 Marketing Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
        12.1.3 Marketing Channel Development Trend
    12.2 Market Positioning
        12.2.1 Pricing Strategy
        12.2.2 Brand Strategy
        12.2.3 Target Client
    12.3 Distributors/Traders List

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes Threat
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs/Customer Preference Change
    13.3 Economic/Political Environmental Change

14 Global Gene Therapy Market Forecast (2018-2025)
    14.1 Global Gene Therapy Sales Volume, Revenue and Price Forecast (2018-2025)
       14.1.1 Global Gene Therapy Sales Volume and Growth Rate Forecast (2018-2025)
       14.1.2 Global Gene Therapy Revenue and Growth Rate Forecast (2018-2025)
       14.1.3 Global Gene Therapy Price and Trend Forecast (2018-2025)
    14.2 Global Gene Therapy Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
       14.2.1 Global Gene Therapy Sales Volume and Growth Rate Forecast by Regions (2018-2025)
       14.2.2 Global Gene Therapy Revenue and Growth Rate Forecast by Regions (2018-2025)
       14.2.3 United States Gene Therapy Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
       14.2.4 Europe Gene Therapy Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
       14.2.5 China Gene Therapy Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
       14.2.6 Japan Gene Therapy Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
       14.2.7 Southeast Asia Gene Therapy Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
       14.2.8 India Gene Therapy Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
    14.3 Global Gene Therapy Sales Volume, Revenue and Price Forecast by Type (2018-2025)
       14.3.1 Global Gene Therapy Sales Forecast by Type (2018-2025)
       14.3.2 Global Gene Therapy Revenue Forecast by Type (2018-2025)
       14.3.3 Global Gene Therapy Price Forecast by Type (2018-2025)
    14.4 Global Gene Therapy Sales Volume Forecast by Application (2018-2025)

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology/Research Approach
        16.1.1 Research Programs/Design
        16.1.2 Market Size Estimation
        16.1.3 Market Breakdown and Data Triangulation
    16.2 Data Source
        16.2.1 Secondary Sources
        16.2.2 Primary Sources
    16.3 Disclaimer
List of Tables and Figures

    Figure Product Picture of Gene Therapy
    Figure Global Gene Therapy Sales Volume Comparison (K Units) by Type
    Figure Global Gene Therapy Sales Volume Market Share by Type (Product Category) in
    Figure Ex vivo Product Picture
    Figure In vivo Product Picture
    Figure Global Gene Therapy Sales Comparison (K Units) by Application
    Figure Global Sales Market Share of Gene Therapy by Application in
    Figure Cancer Diseases Examples
    Table Key Downstream Customer in Cancer Diseases
    Figure Monogenic Diseases Examples
    Table Key Downstream Customer in Monogenic Diseases
    Figure Infectious Diseases Examples
    Table Key Downstream Customer in Infectious Diseases
    Figure Cardiovascular Diseases Examples
    Table Key Downstream Customer in Cardiovascular Diseases
    Figure Others Examples
    Table Key Downstream Customer in Others
    Figure Global Gene Therapy Market Size (Million USD) by Regions
    Figure United States Gene Therapy Revenue (Million USD) and Growth Rate
    Figure Europe Gene Therapy Revenue (Million USD) and Growth Rate
    Figure China Gene Therapy Revenue (Million USD) and Growth Rate
    Figure Japan Gene Therapy Revenue (Million USD) and Growth Rate
    Figure Southeast Asia Gene Therapy Revenue (Million USD) and Growth Rate
    Figure India Gene Therapy Revenue (Million USD) and Growth Rate
    Figure Global Gene Therapy Sales Volume (K Units) and Growth Rate
    Figure Global Gene Therapy Revenue (Million USD) and Growth Rate
    Figure Global Market Major Players Gene Therapy Sales Volume (K Units)
    Table Global Gene Therapy Sales (K Units) of Key Players/Suppliers
    Table Global Gene Therapy Sales Share by Players/Suppliers
    Figure  Gene Therapy Sales Share by Players/Suppliers
    Figure  Gene Therapy Sales Share by Players/Suppliers
    Figure Global Gene Therapy Revenue (Million USD) by Players/Suppliers
    Table Global Gene Therapy Revenue (Million USD) by Players/Suppliers
    Table Global Gene Therapy Revenue Share by Players/Suppliers
    Table  Global Gene Therapy Revenue Share by Players
    Table  Global Gene Therapy Revenue Share by Players
    Table Global Gene Therapy Sales (K Units) and Market Share by Type
    Table Global Gene Therapy Sales Share (K Units) by Type
    Figure Sales Market Share of Gene Therapy by Type
    Figure Global Gene Therapy Sales Growth Rate by Type
    Table Global Gene Therapy Revenue (Million USD) and Market Share by Type
    Table Global Gene Therapy Revenue Share by Type
    Figure Revenue Market Share of Gene Therapy by Type
    Figure Global Gene Therapy Revenue Growth Rate by Type
    Table Global Gene Therapy Sales Volume (K Units) and Market Share by Region
    Table Global Gene Therapy Sales Share by Region
    Figure Sales Market Share of Gene Therapy by Region
    Figure Global Gene Therapy Sales Growth Rate by Region in
    Table Global Gene Therapy Revenue (Million USD) and Market Share by Region
    Table Global Gene Therapy Revenue Share (%) by Region
    Figure Revenue Market Share of Gene Therapy by Region
    Figure Global Gene Therapy Revenue Growth Rate by Region in
    Table Global Gene Therapy Revenue (Million USD) and Market Share by Region
    Table Global Gene Therapy Revenue Share (%) by Region
    Figure Revenue Market Share of Gene Therapy by Region
    Figure Global Gene Therapy Revenue Market Share by Region in
    Table Global Gene Therapy Sales Volume (K Units) and Market Share by Application
    Table Global Gene Therapy Sales Share (%) by Application
    Figure Sales Market Share of Gene Therapy by Application
    Figure Global Gene Therapy Sales Market Share by Application
    Figure United States Gene Therapy Sales (K Units) and Growth Rate
    Figure United States Gene Therapy Revenue (Million USD) and Growth Rate
    Figure United States Gene Therapy Sales Price (USD/Unit) Trend
    Table United States Gene Therapy Sales Volume (K Units) by Players
    Table United States Gene Therapy Sales Volume Market Share by Players
    Figure United States Gene Therapy Sales Volume Market Share by Players in
    Table United States Gene Therapy Sales Volume (K Units) by Type
    Table United States Gene Therapy Sales Volume Market Share by Type
    Figure United States Gene Therapy Sales Volume Market Share by Type in
    Table United States Gene Therapy Sales Volume (K Units) by Application
    Table United States Gene Therapy Sales Volume Market Share by Application
    Figure United States Gene Therapy Sales Volume Market Share by Application in
    Figure Europe Gene Therapy Sales (K Units) and Growth Rate
    Figure Europe Gene Therapy Revenue (Million USD) and Growth Rate
    Figure Europe Gene Therapy Sales Price (USD/Unit) Trend
    Table Europe Gene Therapy Sales Volume (K Units) by Players
    Table Europe Gene Therapy Sales Volume Market Share by Players
    Figure Europe Gene Therapy Sales Volume Market Share by Players in
    Table Europe Gene Therapy Sales Volume (K Units) by Type
    Table Europe Gene Therapy Sales Volume Market Share by Type
    Figure Europe Gene Therapy Sales Volume Market Share by Type in
    Table Europe Gene Therapy Sales Volume (K Units) by Application
    Table Europe Gene Therapy Sales Volume Market Share by Application
    Figure Europe Gene Therapy Sales Volume Market Share by Application in
    Figure China Gene Therapy Sales (K Units) and Growth Rate
    Figure China Gene Therapy Revenue (Million USD) and Growth Rate
    Figure China Gene Therapy Sales Price (USD/Unit) Trend
    Table China Gene Therapy Sales Volume (K Units) by Players
    Table China Gene Therapy Sales Volume Market Share by Players
    Figure China Gene Therapy Sales Volume Market Share by Players in
    Table China Gene Therapy Sales Volume (K Units) by Type
    Table China Gene Therapy Sales Volume Market Share by Type
    Figure China Gene Therapy Sales Volume Market Share by Type in
    Table China Gene Therapy Sales Volume (K Units) by Application
    Table China Gene Therapy Sales Volume Market Share by Application
    Figure China Gene Therapy Sales Volume Market Share by Application in
    Figure Japan Gene Therapy Sales (K Units) and Growth Rate
    Figure Japan Gene Therapy Revenue (Million USD) and Growth Rate
    Figure Japan Gene Therapy Sales Price (USD/Unit) Trend
    Table Japan Gene Therapy Sales Volume (K Units) by Players
    Table Japan Gene Therapy Sales Volume Market Share by Players
    Figure Japan Gene Therapy Sales Volume Market Share by Players in
    Table Japan Gene Therapy Sales Volume (K Units) by Type
    Table Japan Gene Therapy Sales Volume Market Share by Type
    Figure Japan Gene Therapy Sales Volume Market Share by Type in
    Table Japan Gene Therapy Sales Volume (K Units) by Application
    Table Japan Gene Therapy Sales Volume Market Share by Application
    Figure Japan Gene Therapy Sales Volume Market Share by Application in
    Figure Southeast Asia Gene Therapy Sales (K Units) and Growth Rate
    Figure Southeast Asia Gene Therapy Revenue (Million USD) and Growth Rate
    Figure Southeast Asia Gene Therapy Sales Price (USD/Unit) Trend
    Table Southeast Asia Gene Therapy Sales Volume (K Units) by Players
    Table Southeast Asia Gene Therapy Sales Volume Market Share by Players
    Figure Southeast Asia Gene Therapy Sales Volume Market Share by Players in
    Table Southeast Asia Gene Therapy Sales Volume (K Units) by Type
    Table Southeast Asia Gene Therapy Sales Volume Market Share by Type
    Figure Southeast Asia Gene Therapy Sales Volume Market Share by Type in
    Table Southeast Asia Gene Therapy Sales Volume (K Units) by Application
    Table Southeast Asia Gene Therapy Sales Volume Market Share by Application
    Figure Southeast Asia Gene Therapy Sales Volume Market Share by Application in
    Figure India Gene Therapy Sales (K Units) and Growth Rate
    Figure India Gene Therapy Revenue (Million USD) and Growth Rate
    Figure India Gene Therapy Sales Price (USD/Unit) Trend
    Table India Gene Therapy Sales Volume (K Units) by Players
    Table India Gene Therapy Sales Volume Market Share by Players
    Figure India Gene Therapy Sales Volume Market Share by Players in
    Table India Gene Therapy Sales Volume (K Units) by Type
    Table India Gene Therapy Sales Volume Market Share by Type
    Figure India Gene Therapy Sales Volume Market Share by Type in
    Table India Gene Therapy Sales Volume (K Units) by Application
    Table India Gene Therapy Sales Volume Market Share by Application
    Figure India Gene Therapy Sales Volume Market Share by Application in
    Table Sangamo Basic Information List
    Table Sangamo Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin
    Figure Sangamo Gene Therapy Sales Growth Rate
    Figure Sangamo Gene Therapy Sales Global Market Share
    Figure Sangamo Gene Therapy Revenue Global Market Share
    Table Spark Therapeutics Basic Information List
    Table Spark Therapeutics Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin
    Figure Spark Therapeutics Gene Therapy Sales Growth Rate
    Figure Spark Therapeutics Gene Therapy Sales Global Market Share
    Figure Spark Therapeutics Gene Therapy Revenue Global Market Share
    Table Dimension Therapeutics Basic Information List
    Table Dimension Therapeutics Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin
    Figure Dimension Therapeutics Gene Therapy Sales Growth Rate
    Figure Dimension Therapeutics Gene Therapy Sales Global Market Share (2013-2018
    Figure Dimension Therapeutics Gene Therapy Revenue Global Market Share
    Table Avalanche Bio Basic Information List
    Table Avalanche Bio Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin
    Figure Avalanche Bio Gene Therapy Sales Growth Rate
    Figure Avalanche Bio Gene Therapy Sales Global Market Share
    Figure Avalanche Bio Gene Therapy Revenue Global Market Share
    Table Celladon Basic Information List
    Table Celladon Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin
    Figure Celladon Gene Therapy Sales Growth Rate
    Figure Celladon Gene Therapy Sales Global Market Share
    Figure Celladon Gene Therapy Revenue Global Market Share
    Table Vical Basic Information List
    Table Vical Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin
    Figure Vical Gene Therapy Sales Growth Rate
    Figure Vical Gene Therapy Sales Global Market Share (2013-2018
    Figure Vical Gene Therapy Revenue Global Market Share
    Table Advantagene Basic Information List
    Table Advantagene Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin
    Figure Advantagene Gene Therapy Sales Growth Rate
    Figure Advantagene Gene Therapy Sales Global Market Share
    Figure Advantagene Gene Therapy Revenue Global Market Share
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Gene Therapy
    Figure Manufacturing Process Analysis of Gene Therapy
    Figure Gene Therapy Industrial Chain Analysis
    Table Raw Materials Sources of Gene Therapy Major Players in
    Table Major Buyers of Gene Therapy
    Table Distributors/Traders List
    Figure Global Gene Therapy Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
    Figure Global Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Figure Global Gene Therapy Price (USD/Unit) and Trend Forecast (2018-2025)
    Table Global Gene Therapy Sales Volume (K Units) Forecast by Regions (2018-2025)
    Figure Global Gene Therapy Sales Volume Market Share Forecast by Regions (2018-2025)
    Figure Global Gene Therapy Sales Volume Market Share Forecast by Regions in 2025
    Table Global Gene Therapy Revenue (Million USD) Forecast by Regions (2018-2025)
    Figure Global Gene Therapy Revenue Market Share Forecast by Regions (2018-2025)
    Figure Global Gene Therapy Revenue Market Share Forecast by Regions in 2025
    Figure United States Gene Therapy Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
    Figure United States Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Figure Europe Gene Therapy Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
    Figure Europe Gene Therapy Revenue and Growth Rate Forecast (2018-2025)
    Figure China Gene Therapy Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
    Figure China Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Figure Japan Gene Therapy Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
    Figure Japan Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Figure Southeast Asia Gene Therapy Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
    Figure Southeast Asia Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Figure India Gene Therapy Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
    Figure India Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Table Global Gene Therapy Sales (K Units) Forecast by Type (2018-2025)
    Figure Global Gene Therapy Sales Volume Market Share Forecast by Type (2018-2025)
    Table Global Gene Therapy Revenue (Million USD) Forecast by Type (2018-2025)
    Figure Global Gene Therapy Revenue Market Share Forecast by Type (2018-2025)
    Table Global Gene Therapy Price (USD/Unit) Forecast by Type (2018-2025)
    Table Global Gene Therapy Sales (K Units) Forecast by Application (2018-2025)
    Figure Global Gene Therapy Sales Market Share Forecast by Application (2018-2025)
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

Key Market Players

Beyond the listed companies, several additional players contribute significantly to the global gene therapy market:

  • Sangamo Therapeutics (U.S.)
  • Spark Therapeutics (U.S.)
  • Dimension Therapeutics (U.S.)
  • Avalanche Biotechnologies (U.S.)
  • Celladon Corporation (U.S.)
  • Vical Incorporated (U.S.)
  • Advantagene Inc. (U.S.)
  • Bluebird Bio (U.S.)
  • Novartis AG (Switzerland) – CAR-T and gene therapy portfolio.
  • Gilead Sciences/Kite Pharma (U.S.) – oncology-focused gene therapies.
  • Pfizer Inc. (U.S.) – expanding pipeline in rare diseases.
  • Roche/Genentech (Switzerland/U.S.) – oncology and ophthalmology gene therapies.
  • UniQure N.V. (Netherlands) – pioneering AAV-based therapies.
  • REGENXBIO Inc. (U.S.) – AAV vector technology.
  • Orchard Therapeutics (U.K.) – rare disease therapies.
  • Editas Medicine (U.S.) – CRISPR-based gene editing.
  • CRISPR Therapeutics (Switzerland) – gene editing for blood disorders.
  • Intellia Therapeutics (U.S.) – in vivo CRISPR therapies.
  • Beam Therapeutics (U.S.) – base editing technologies.

Segments Analysis

By Product Type

  • Ex vivo Gene Therapy – cells modified outside the body and reintroduced.
  • In vivo Gene Therapy – direct delivery of genetic material into the patient.

By Application

  • Cancer Diseases – CAR-T therapies, tumor suppressor gene delivery.
  • Monogenic Diseases – hemophilia, muscular dystrophy, cystic fibrosis.
  • Infectious Diseases – HIV, hepatitis, emerging viral infections.
  • Cardiovascular Diseases – ischemic heart disease, heart failure.
  • Others – ophthalmology, neurology, metabolic disorders.

Regional Analysis – Highlights

  • North America: Largest market; strong presence of biotech firms, advanced healthcare infrastructure, and FDA approvals.
  • Europe: Germany, U.K., and France lead; EMA supports rare disease therapies.
  • Asia-Pacific: China and Japan expanding R&D; India and South Korea emerging with clinical trials.
  • Latin America: Brazil and Argentina show growing adoption in oncology and rare disease treatments.
  • Middle East & Africa: Early-stage adoption; demand linked to healthcare modernization and rare disease initiatives.

FAQ's

Yes, we are providing all research support to get resolve all queries and concerns regarding the report. For all our clients.
Yes, we are providing complete customization in every report to fulfill your business needs.
Yes, we are providing regional and countries level analysis in the report, please mention the countries you are looking.
Yes, we are providing a discount for individuals and startups.
We offer access to more than one million market research reports. If the specific topic you need is not listed on our website, simply email us your requirements at [email protected]. Our research team will review your request and provide a customized report or the most relevant available study. We

Similar Reports